PrairieView Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $324K | Buy |
3,726
+128
| +4% | +$11.1K | 0.03% | 106 |
|
|
2025
Q1 | $323K | Buy |
3,598
+25
| +0.7% | +$2.24K | 0.03% | 105 |
|
|
2024
Q4 | $285K | Sell |
3,573
-394
| -10% | -$31.4K | 0.03% | 109 |
|
|
2024
Q3 | $357K | Sell |
3,967
-14
| -0.4% | -$1.26K | 0.04% | 98 |
|
|
2024
Q2 | $313K | Buy |
3,981
+17
| +0.4% | +$1.34K | 0.04% | 114 |
|
|
2024
Q1 | $346K | Sell |
3,964
-3,052
| -44% | -$266K | 0.04% | 95 |
|
|
2023
Q4 | $578K | Sell |
7,016
-457
| -6% | -$37.6K | 0.07% | 71 |
|
|
2023
Q3 | $585K | Sell |
7,473
-203
| -3% | -$15.9K | 0.08% | 66 |
|
|
2023
Q2 | $676K | Sell |
7,676
-30
| -0.4% | -$2.64K | 0.09% | 65 |
|
|
2023
Q1 | $621K | Buy |
7,706
+167
| +2% | +$13.5K | 0.09% | 65 |
|
|
2022
Q4 | $585K | Buy |
7,539
+114
| +2% | +$8.85K | 0.09% | 64 |
|
|
2022
Q3 | $600K | Sell |
7,425
-575
| -7% | -$46.5K | 0.1% | 63 |
|
|
2022
Q2 | $718K | Buy |
8,000
+224
| +3% | +$20.1K | 0.11% | 62 |
|
|
2022
Q1 | $863K | Buy |
7,776
+80
| +1% | +$8.88K | 0.12% | 55 |
|
|
2021
Q4 | $796K | Buy |
7,696
+61
| +0.8% | +$6.31K | 0.11% | 51 |
|
|
2021
Q3 | $957K | Buy |
7,635
+84
| +1% | +$10.5K | 0.14% | 45 |
|
|
2021
Q2 | $937K | Buy |
7,551
+39
| +0.5% | +$4.84K | 0.14% | 45 |
|
|
2021
Q1 | $887K | Buy |
7,512
+74
| +1% | +$8.74K | 0.14% | 46 |
|
|
2020
Q4 | $871K | Sell |
7,438
-74
| -1% | -$8.67K | 0.15% | 45 |
|
|
2020
Q3 | $781K | Buy |
7,512
+75
| +1% | +$7.8K | 0.16% | 41 |
|
|
2020
Q2 | $682K | Buy |
7,437
+8
| +0.1% | +$734 | 0.15% | 43 |
|
|
2020
Q1 | $670K | Buy |
7,429
+59
| +0.8% | +$5.32K | 0.17% | 44 |
|
|
2019
Q4 | $836K | Buy |
7,370
+509
| +7% | +$57.7K | 0.18% | 41 |
|
|
2019
Q3 | $745K | Buy |
+6,861
| New | +$745K | 0.17% | 46 |
|